HK1198587A1 - 異噻唑並吡啶- -甲酰胺和它們作為藥物的用途 - Google Patents

異噻唑並吡啶- -甲酰胺和它們作為藥物的用途

Info

Publication number
HK1198587A1
HK1198587A1 HK14112083A HK14112083A HK1198587A1 HK 1198587 A1 HK1198587 A1 HK 1198587A1 HK 14112083 A HK14112083 A HK 14112083A HK 14112083 A HK14112083 A HK 14112083A HK 1198587 A1 HK1198587 A1 HK 1198587A1
Authority
HK
Hong Kong
Prior art keywords
isothiazolopyridine
carboxamides
pharmaceuticals
Prior art date
Application number
HK14112083A
Other languages
English (en)
Inventor
Hauke Szillat
Thomas Leeuw
Martin Lorenz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198587A1 publication Critical patent/HK1198587A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK14112083A 2011-12-20 2014-12-01 異噻唑並吡啶- -甲酰胺和它們作為藥物的用途 HK1198587A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11306711 2011-12-20
PCT/EP2012/075932 WO2013092574A1 (en) 2011-12-20 2012-12-18 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
HK1198587A1 true HK1198587A1 (zh) 2015-04-30

Family

ID=47429823

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112083A HK1198587A1 (zh) 2011-12-20 2014-12-01 異噻唑並吡啶- -甲酰胺和它們作為藥物的用途

Country Status (24)

Country Link
US (1) US9260454B2 (zh)
EP (1) EP2794618B1 (zh)
JP (1) JP6099669B2 (zh)
KR (1) KR20140103150A (zh)
CN (1) CN104136443B (zh)
AR (1) AR089329A1 (zh)
AU (1) AU2012357864B2 (zh)
BR (1) BR112014015033A2 (zh)
CA (1) CA2856964A1 (zh)
CY (1) CY1118854T1 (zh)
DK (1) DK2794618T3 (zh)
ES (1) ES2613826T3 (zh)
HK (1) HK1198587A1 (zh)
HR (1) HRP20170159T1 (zh)
HU (1) HUE033049T2 (zh)
IL (1) IL232809A (zh)
LT (1) LT2794618T (zh)
MX (1) MX2014007465A (zh)
PL (1) PL2794618T3 (zh)
PT (1) PT2794618T (zh)
RU (1) RU2014129903A (zh)
SG (1) SG11201402623RA (zh)
SI (1) SI2794618T1 (zh)
WO (1) WO2013092574A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6814730B2 (ja) * 2014-09-05 2021-01-20 ジェネンテック， インコーポレイテッド 治療用化合物およびその使用
WO2017030892A1 (en) * 2015-08-14 2017-02-23 Reaction Biology Corp. Histone deacetylase inhibitors and methods for use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892745A (en) * 1972-11-20 1975-07-01 Sankyo Co Isoxazolone derivatives and process for preparing the same
US3965107A (en) 1974-07-08 1976-06-22 Rohm And Haas Company Isothiazolopyridinones
LU84091A1 (fr) * 1982-04-16 1984-03-02 Oreal Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides
US4968713A (en) 1989-07-31 1990-11-06 Merck & Co., Inc. Certain imidazole compounds as transglutaminase inhibitors
DE10054687A1 (de) 2000-11-03 2002-05-16 N Zyme Biotec Gmbh Inhibitoren von Transglutaminasen
EP1613608A1 (en) * 2003-04-01 2006-01-11 Eli Lilly And Company Phospholipase inhibitors
EP1615900A1 (en) * 2003-04-01 2006-01-18 Eli Lilly And Company Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
GB0314262D0 (en) 2003-06-19 2003-07-23 Univ Nottingham Trent Novel compounds and methods of using the same
JP2007529468A (ja) * 2004-03-16 2007-10-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ベンズイソオキサゾール
DE102006014688A1 (de) 2006-03-28 2007-10-04 Sanofi-Aventis Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102006052755A1 (de) 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
WO2011060321A1 (en) 2009-11-16 2011-05-19 Chdi, Inc. Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
WO2011157827A1 (de) * 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen

Also Published As

Publication number Publication date
CN104136443B (zh) 2017-01-18
IL232809A0 (en) 2014-08-03
US9260454B2 (en) 2016-02-16
AU2012357864A1 (en) 2014-07-03
CN104136443A (zh) 2014-11-05
CA2856964A1 (en) 2013-06-27
DK2794618T3 (en) 2017-02-20
BR112014015033A2 (pt) 2017-06-13
AR089329A1 (es) 2014-08-13
PT2794618T (pt) 2017-01-17
CY1118854T1 (el) 2018-01-10
IL232809A (en) 2017-05-29
SG11201402623RA (en) 2014-09-26
LT2794618T (lt) 2017-02-27
JP6099669B2 (ja) 2017-03-22
JP2015500855A (ja) 2015-01-08
EP2794618B1 (en) 2016-11-16
EP2794618A1 (en) 2014-10-29
US20140296169A1 (en) 2014-10-02
HUE033049T2 (hu) 2017-11-28
KR20140103150A (ko) 2014-08-25
MX2014007465A (es) 2014-07-30
AU2012357864B2 (en) 2017-03-02
PL2794618T3 (pl) 2017-05-31
WO2013092574A1 (en) 2013-06-27
RU2014129903A (ru) 2016-02-10
SI2794618T1 (sl) 2017-03-31
HRP20170159T1 (hr) 2017-03-24
ES2613826T3 (es) 2017-05-26

Similar Documents

Publication Publication Date Title
HUS2100012I1 (hu) 4-Imidazopiridazin-1-il-benzamidok és 4-imidazotriazin-1-il-benzamidok mint BTK-gátlók
IL233051B (en) Anti-phf-tau antibodies and uses thereof
HK1198433A1 (zh) -酰基二肽衍生物及其應用
GB201111705D0 (en) Compounds and their use
IL229844B (en) Anti-psgl-1 antibodies and their use
HK1191034A1 (zh) -羧烷基耳他汀類及其應用
GB201110783D0 (en) Methods and uses
IL231082A0 (en) Pyrimido-pyridazinone compounds and their use
EP2688588A4 (en) FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC
GB201111630D0 (en) Novel compounds and their use
GB201116774D0 (en) Uses and methods
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
EP2716359A4 (en) COMPLEX AND USES THEREOF
GB201111775D0 (en) Compounds and uses thereof
GB201114448D0 (en) Compounds and their use
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
GB201106357D0 (en) Composition and uses thereof
EP2693879A4 (en) MIGRASTATINES AND THEIR USES
HK1198587A1 (zh) 異噻唑並吡啶- -甲酰胺和它們作為藥物的用途
GB201108490D0 (en) Methods and uses
PT2734522T (pt) 4-imidazopiridazina-1-il-benzamidas e 4-imidazotriazin-1- il-benzamidas como inibidores de btk
GB201104444D0 (en) Compounds and their use
GB201121551D0 (en) Compounds and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201220